top of page


EDMONTON, Alberta, November 27, 2015 – BioNeutra Global Corporation (CSE: BGA) (“BioNeutra” or the “Company“) announces that, subject to regulatory approval, the Corporation intends to complete an offering of 2,500,000 common shares (“Common Shares”) at a price of $0.40 per Common Share for gross proceeds of $1,000,000 by way of a private placement (the “Private Placement”).

BioNeutra intends to use the proceeds from the Private Placement for general working capital.

Additional details regarding the private placement can be found in the Form 9 filed on May 20, 2015 in accordance with the rules of the Canadian Securities Exchange, a copy of which is accessible at under the Corporation’s profile.


bottom of page